Stay updated on ARO-APOC3 in FCS Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in FCS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 to reflect a new deployment; study content and user-facing information remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-15T06:17:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a new PubMed citation for Loomba et al. on Plozasiran and removed the prior 'Online ahead of print' listing for the same study. This updates the Publications section to reflect the latest PALISADE-related literature.
    Difference
    0.0%
    Check dated 2026-05-08T10:06:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s site revision/version indicator was updated from v3.5.2 to v3.5.3. This reflects an administrative/site build update rather than a change to the study information presented.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:11.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:40:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Adds a new publication citation to the Publications section: Loomba et al., Aliment Pharmacol Ther. 2026 (PALISADE post hoc analysis).
    Difference
    0.0%
    Check dated 2026-04-09T21:32:56.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:09:39.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.